caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1962442699

Kin LamMD

Hematology-OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kin Lam's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 27 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
3021,948
Norland Ng
Hematology-Oncology · New York, NY
1142,515
ENZO CLINICAL LABS, INC.106450
THIRD AVENUE OPEN MRI, INC57101
BETH ISRAEL MEDICAL CENTER47261
TRASI, SUNIL4778
Calvin Lo
Diagnostic Radiology · New York, NY
44110
Barbara Kuang
Diagnostic Radiology · New York, NY
3162
Heather Osborne
Diagnostic Radiology · New York, NY
2851
Jian Liang
Podiatry · New York, NY
2173
Michael Liou
Interventional Cardiology · New York, NY
1967
Steve Tam
Internal Medicine · New York, NY
1898
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,453
Unique beneficiaries
—
Total services
2,781
Distinct HCPCS
25
Medicare payment
$149K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — top quintile (cohort median 883).
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
84.6
Cost
90.4
Improvement activities
40.0
Promoting interop.
90.0
Payment adjustment
1.05%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
7,492
Beneficiaries
—
Total drug cost
$6.8M
Distinct drugs
154
Brand share
23.7%
Top prescribed drugs
Rosuvastatin Calcium345 claims
Amlodipine Besylate310 claims
Losartan Potassium285 claims
Atorvastatin Calcium271 claims
Ammonium Lactate164 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$9K
Payment records
359
By payment type
Food and Beverage$9K
Education$205